Partner with Neelyx Labs
FOR LABORATORIES
Building laboratory connections
Neelyx Labs partners with local, regional, and national diagnostic labs to serve their community’s diagnostic needs by providing licensing, expertise, and IT infrastructure.
LICENSING
➠ Procure regulatory licensing approval from government bodies
➠ Leverage existing licensing and protocols from Neelyx
EXPERTISE
➠ Setup and implementation training
➠ Advise on procuring reagents and supplies
➠ Consultation on process optimization
INFRASTRUCTURE
➠ Scalable custom LIMS on Google Platform
➠ Seamless integration with regulatory and healthcare information portals
Ready to launch your new diagnostic or therapeutic?
We have a state-of-the-art, in-house laboratory.
We have an experienced team of IRB Specialists.
We are CLIA-certified to develop high-complexity molecular and genetic assays.
OUR SERVICES
FROM THE OFFICE…
Assessment
Proposal
Regulatory & Ethics
IRB
Protocol Development
Clinical Trials
Bioinformatics
Product Deployment
FDA Submission
FROM THE LABORATORY…
Molecular diagnostics
Small RNA & miRNA
PCR Multiplexing
Biochemistry
Microbiology & Microbiome
Transcriptomics
Sequencing
Genomics
Therapeutic Validation
FEATURED SCIENCE:
OpenSeq COVID-19 Variant NGS Test
Neelyx Labs offers the OpenSeq COVID-19 Variant NGS Test to identify which COVID-19 lineage and specific variants a patient has.
There are a multitude of therapeutics available for COVID-19 infection, and NGS testing results can help a physician choose the best option for a patient based on the particular COVID-19 variant present.
We have the capability to provide this information to all patients who test positive for COVID-19 on an RT-PCR test.
Neelyx Labs uses cutting-edge, whole-genome, deep sequencing on the Oxford Nanopore platform to provide COVID-19 Variant NGS Testing.
This test was developed within our own laboratory by our team of innovative senior scientists. We are open to laboratory partnership opportunities that involve further utilizing Next Generation Sequencing for additional clinical diagnostic solutions. We have the capacity to develop and execute these testing solutions in-house.
